NCT06545929View on ClinicalTrials.gov

Study of Sunobinop on Craving in Alcohol Use Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 28, 2025

Primary Completion Date

July 14, 2025

Study Completion Date

July 14, 2025

Conditions
Alcohol Use Disorder
Interventions
DRUG

Sunobinop

1 tablet taken orally at bedtime

DRUG

Placebo to match sunobinop

1 tablet taken orally at bedtime

Trial Locations (1)

43212

Ohio Clinical Trials, Columbus

Sponsors
All Listed Sponsors
collaborator

Purdue Pharma LP

INDUSTRY

lead

Imbrium Therapeutics

INDUSTRY

NCT06545929 - Study of Sunobinop on Craving in Alcohol Use Disorder | Biotech Hunter | Biotech Hunter